D. E. Shaw & Co., Inc. Merrimack Pharmaceuticals Inc Transaction History

D. E. Shaw & Co., Inc.

  • $107 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 14, 2019
SELL
$4.16 - $6.05 $81,481 - $118,501
-19,587 Closed
0 $0
Q2 2019

Aug 14, 2019
SELL
$4.39 - $5.66 $382,175 - $492,736
-87,056 Reduced 81.63%
19,587 $119,000
Q1 2019

May 15, 2019
BUY
$3.19 - $5.73 $164,345 - $295,203
51,519 Added 93.46%
106,643 $741,000
Q4 2018

Feb 14, 2019
BUY
$2.95 - $4.15 $71,310 - $100,317
24,173 Added 78.1%
55,124 $213,000
Q3 2018

Nov 14, 2018
BUY
$3.91 - $4.66 $121,018 - $144,231
30,951 New
30,951 $165,000

Others Institutions Holding MACK

# of Institutions
1
Shares Held
77
Call Options Held
0
Put Options Held
0
View Full List

About MERRIMACK PHARMACEUTICALS INC

MACK Quotes by TradingView
  • Ticker MACK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,410,200
  • Market Cap $203M
  • Description
  • Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
More about MACK
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email